Hypoxia-repressed lncRNA ZNF213-AS1 restrains p65-driven epithelial–mesenchymal transition in ovarian cancer
Biochemical and Biophysical Research Communications · 2026-09 · 831 · 154309
DOI: 10.1016/j.bbrc.2026.154309 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026-09. Verfasst von Caixia Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200072, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Epithelial-Mesenchymal Transition, RNA, Long Noncoding, Transcription Factor RelA. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Hypoxia promotes ovarian cancer progression, EMT and platinum resistance, but the lncRNA mediators involved remain unclear. Here, we identified ZNF213-AS1 as a downregulated lncRNA in ovarian cancer by analyzing TCGA-OV and GTEx datasets. Low ZNF213-AS1 expression predicted poor overall survival and was associated with hypoxia, EMT, NF-κB and IL6/JAK/STAT3 signatures. ZNF213-AS1 was relatively abundant and enriched in the chromatin-associated fraction. Hypoxia reduced ZNF213-AS1 expression in ovarian cancer cells, but this repression was not rescued by HIF1α knockout or mutation of the predicted HRE motif, suggesting a noncanonical hypoxic regulatory mechanism. Functionally, ZNF213-AS1 overexpression suppressed hypoxia-induced colony formation, invasion and cisplatin resistance, whereas ZNF213-AS1 knockdown enhanced these phenotypes. Mechanistically, ZNF213-AS1 inhibited NF-κB reporter activity and reduced NF-κB/STAT3/EMT-related gene expression. RNA pull-down and RIP assays showed that ZNF213-AS1 associates with RELA/p65-containing NF-κB complexes. Moreover, p65 re-expression partially reversed the inhibitory effects of ZNF213-AS1 on STAT3 activation, EMT markers and xenograft growth. These findings define a hypoxia-repressed ZNF213-AS1-p65 axis that limits NF-κB/STAT3-driven EMT and platinum-resistant ovarian cancer progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200072, China.
- Department of Gynecology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
- Department of Gynecology and Obstetrics, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200072, China. Electronic address: 18817367694@163.com.
- Department of Gynecology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China. Electronic address: ywh8708@163.com.
Zitieren
APA
Li, C., Chen, R., Zhao, Y., Li, M., Zhou, W., & Yang, W. (2026). Hypoxia-repressed lncRNA ZNF213-AS1 restrains p65-driven epithelial–mesenchymal transition in ovarian cancer. Biochemical and Biophysical Research Communications, 831, 154309. https://doi.org/10.1016/j.bbrc.2026.154309
Vancouver
Li C, Chen R, Zhao Y, Li M, Zhou W, Yang W. Hypoxia-repressed lncRNA ZNF213-AS1 restrains p65-driven epithelial–mesenchymal transition in ovarian cancer. Biochemical and Biophysical Research Communications. 2026;831:154309. doi:10.1016/j.bbrc.2026.154309
BibTeX
@article{Li2026,
author = {Li, Caixia and Chen, Rong and Zhao, Yujie and Li, Mengjie and Zhou, Wenni and Yang, Weihong},
title = {Hypoxia-repressed lncRNA ZNF213-AS1 restrains p65-driven epithelial–mesenchymal transition in ovarian cancer},
journal = {Biochemical and Biophysical Research Communications},
year = {2026},
volume = {831},
pages = {154309},
doi = {10.1016/j.bbrc.2026.154309}
}
EUVIMED